490.68

+0.85%↑

CTAS

193

+0.12%↑

FDX

312.25

+0.07%↑

HEICO

356.64

+1.05%↑

HEICA

273.47

+0.16%↑

490.68

+0.85%↑

CTAS

193

+0.12%↑

FDX

312.25

+0.07%↑

HEICO

356.64

+1.05%↑

HEICA

273.47

+0.16%↑

490.68

+0.85%↑

CTAS

193

+0.12%↑

FDX

312.25

+0.07%↑

HEICO

356.64

+1.05%↑

HEICA

273.47

+0.16%↑

490.68

+0.85%↑

CTAS

193

+0.12%↑

FDX

312.25

+0.07%↑

HEICO

356.64

+1.05%↑

HEICA

273.47

+0.16%↑

490.68

+0.85%↑

CTAS

193

+0.12%↑

FDX

312.25

+0.07%↑

HEICO

356.64

+1.05%↑

HEICA

273.47

+0.16%↑

Home・Akciju saraksts・Cross Country Healthcare Inc

Cross Country Healthcare Inc

Slēgts

SektorsRūpniecība

8.4 2.82

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

8.01

Max

8.58

Galvenie mērījumi
By Trading Economics
Ienākumi	1.9M -4.8M
Pārdošana	-24M 250M
EPS	0.03
Peļņas marža	-1.909
Darbinieki	9,605
EBITDA	86K -993K

Rekomendācijas
By TipRanks
Rekomendācijas	Neitrāls
Prognoze 12 mēnešiem	+17.66% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 3. marts

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-121M 279M
Iepriekšējā atvēršanas cena	5.58
Iepriekšējā slēgšanas cena	8.4

Ziņu noskaņojums

By Acuity

34%

66%

124 / 454 Rangs Industrials

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bullish Evidence

13.52 / 13.92 Atbalsts un pretestība

Cross Country Healthcare Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 12. janv. 23:54 UTC

Tirgus saruna

CBA Could Underperform Again in 2026 -- Market Talk

2026. g. 12. janv. 23:48 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. janv. 23:48 UTC

Tirgus saruna

Nikkei May Rise on Weaker Yen -- Market Talk

2026. g. 12. janv. 23:43 UTC

Tirgus saruna

Gold Edges Lower on Likely Technical Correction -- Market Talk

2026. g. 12. janv. 23:18 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

2026. g. 12. janv. 21:56 UTC

Tirgus saruna

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Health Care Roundup: Market Talk

2026. g. 12. janv. 21:50 UTC

Tirgus saruna

Peļņas

Auto & Transport Roundup: Market Talk

2026. g. 12. janv. 21:18 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 12. janv. 21:18 UTC

Tirgus saruna

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

2026. g. 12. janv. 20:54 UTC

Peļņas

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

2026. g. 12. janv. 20:48 UTC

Tirgus saruna

Oil Futures Settle Higher in Choppy Trade -- Market Talk

2026. g. 12. janv. 20:33 UTC

Tirgus saruna

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

2026. g. 12. janv. 20:18 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

2026. g. 12. janv. 20:18 UTC

Iegādes, apvienošanās, pārņemšana

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

2026. g. 12. janv. 19:39 UTC

Tirgus saruna

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

2026. g. 12. janv. 19:36 UTC

Tirgus saruna

Gold and Silver Set New Records on Fed Probe -- Market Talk

2026. g. 12. janv. 19:36 UTC

Tirgus saruna

Global Forex and Fixed Income Roundup: Market Talk

2026. g. 12. janv. 19:33 UTC

Tirgus saruna

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

2026. g. 12. janv. 19:24 UTC

Iegādes, apvienošanās, pārņemšana

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

2026. g. 12. janv. 19:22 UTC

Iegādes, apvienošanās, pārņemšana

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

2026. g. 12. janv. 18:21 UTC

Iegādes, apvienošanās, pārņemšana

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

2026. g. 12. janv. 18:20 UTC

Iegādes, apvienošanās, pārņemšana

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

2026. g. 12. janv. 18:19 UTC

Tirgus saruna

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

2026. g. 12. janv. 18:16 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

2026. g. 12. janv. 18:09 UTC

Tirgus saruna

Global Equities Roundup: Market Talk

2026. g. 12. janv. 18:09 UTC

Tirgus saruna

Baidu's Outlook Bodes Well For Shares -- Market Talk

2026. g. 12. janv. 18:01 UTC

Iegādes, apvienošanās, pārņemšana

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

2026. g. 12. janv. 18:00 UTC

Tirgus saruna

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Salīdzinājums

Cenas izmaiņa

Cross Country Healthcare Inc Prognoze

Cenas mērķis

By TipRanks

17.66% augšup

Prognoze 12 mēnešiem

Vidējais 9.66 USD 17.66%

Augstākais 11 USD

Zemākais 8.65 USD

Pamatojoties uz 8 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Cross Country Healthcare Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

8 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 8 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Cross Country Healthcare Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

13.52 / 13.92Atbalsts un pretestība

Recent bullish events outweigh bearish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Noskaņojums

By Acuity

124 / 454 Rangs Rūpniecība

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Cross Country Healthcare Inc

Cross Country Healthcare, Inc. provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services. It also offers staffing solutions for registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments; and clinical and non-clinical professionals on long-term contract assignments, as well as workforce solutions, including MSP, VMS, in- home care, education healthcare, RPO, project management, and other outsourcing and consultative services. This segment provides retained search services for healthcare professionals, as well as contingent search and recruitment process outsourcing services. It serves public and private acute care and non-acute care hospitals, government facilities, local and national healthcare plans, managed care providers, public and charter schools, outpatient clinics, ambulatory care facilities, physician practice groups, and other healthcare providers under the Cross Country brand. Its Physician Staffing segment provides physicians in various specialties, certified registered nurse anesthetists, nurse practitioners, and physician assistants under the Cross Country Locums brand on temporary assignments. It serves various healthcare facilities, such as acute and non-acute care facilities, medical group practices, government facilities, and managed care organizations. The company was founded in 1986 and is headquartered in Boca Raton, Florida.